Organon fills VP-CNS position
Executive Summary
Organon's new VP-central nervous system will be former Wyeth VP for Global Strategy-Depression Portfolio Terrence Moore. In the new position, created by corporate restructuring, Moore will oversee all CNS products, including Asenapine, a schizophrenia and bipolar disorder treatment in Phase III trials...